Images | Sources | Experiment + Assay | Phenotypes | Human Diseases | ||||
---|---|---|---|---|---|---|---|---|
fig.1.c
Kenny AP et al. (2012) |
Xla Wt + bmp2 MO
NF18-20 (in situ hybridization) |
|
||||||
fig.5.b
Kenny AP et al. (2012) |
Xla Wt + bmp2 MO
NF20 (immunohistochemistry) |
|
||||||
fig.2.f
Kenny AP et al. (2012) |
Xla Wt + bmp2 MO
NF20 (in situ hybridization) |
|
||||||
fig.2.j
Kenny AP et al. (2012) |
Xla Wt + bmp2 MO
NF37/38 (in situ hybridization) |
|
||||||
fig.2.l
Kenny AP et al. (2012) |
Xla Wt + bmp2 MO
NF37/38 (in situ hybridization) |
|
||||||
fig.2.n
Kenny AP et al. (2012) |
Xla Wt + bmp2 MO
NF37/38 (in situ hybridization) |
|
||||||
fig.2.p
Kenny AP et al. (2012) |
Xla Wt + bmp2 MO
NF37/38 (in situ hybridization) |
|
||||||
fig.2.r
Kenny AP et al. (2012) |
Xla Wt + bmp2 MO
NF37/38 (morphology) |
|
||||||
fig.2.t
Kenny AP et al. (2012) |
Xla Wt + bmp2 MO
NF42 (morphology) |
|